AGE-RELATED MACULAR DEGENERATION
Clinical trials for AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye injection targets Blindness-Causing lesions
Disease control TerminatedThis early-stage study tests the safety of an experimental drug called RO7669330, given as an injection into the eye, for people with geographic atrophy (GA) due to age-related macular degeneration (AMD). The study involves 27 participants and will monitor side effects and eye he…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New eye camera could spot hidden signs of blindness
Knowledge-focused TerminatedThis study tested a new, non-invasive eye imaging method called hyperspectral imaging. It takes pictures of the back of the eye using many different colors of light to find details not visible with standard cameras. About 679 adults with healthy eyes or eye diseases like diabetic…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Center for Eye Research Australia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC